Postoperative treatment of carvedilol following low dose landiolol has preventive effect for atrial fibrillation after coronary artery bypass grafting

Thoracic and Cardiovascular Surgeon

Volumn 57, Issue 8, 2009, Pages 464-467

  Yoshioka, I ^a   Sakurai, M ^a   Namai, A ^a   Kawamura, T ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

adrenoceptor antagonist; Atrial fibrillation; Coronary bypass surgery

Indexed keywords

CARVEDILOL; LANDIOLOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; TACHYCARDIA; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ATRIAL FIBRILLATION; CARBAZOLES; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; PROPANOLAMINES; RETROSPECTIVE STUDIES; TACHYCARDIA; TREATMENT OUTCOME; UREA;

EID: 72849108466     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0029-1186069     Document Type: Article

References (25)

1. Almassi G H., Schowalter T, Nicolosi A C., Aggarwal A, Moritz T E., Henderson W G. et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 1997 226 501-511 discussion 511-513
2. Hogue Jr C W., Hyder M L. Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment. Ann Thorac Surg 2000 69 300-306
3. Maisel W H., Rawn J D., Stevenson W G. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001 135 1061-1073
4. Zaman A G., Archbold R A., Helft G, Paul E A., Curzen N P., Mills P G. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 2000 101 1403-1408
5. Creswell L L., Schuessler R B., Rosenbloom M, Cox J L. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993 56 539-549
6. Crystal E, Connolly S J., Sleik K, Ginger T J., Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002 106 75-80
7. Merrick A F., Odom N J., Keenan D J., Grotte G J. Comparison of propafenone to atenolol for the prophylaxis of postcardiotomy supraventricular tachyarrhythmias: a prospective trial. Eur J Cardiothorac Surg 1995 9 146-149
8. Fujiwara H, Sakurai M, Namai A. Administration of low dose landiolol, an ultrashort-acting -blocker, had preventive effect for postoperative atrial fibrillation after CABG surgery. Gen Thorac Cardiovasc Surg 2009 57 132-137
9. Gilbert E M., Abraham W T., Olsen S, Hattler B, White M, Mealy P et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 1996 94 2817-2825
10. Arumanayagam M, Chan S, Tong S, Sanderson J E. Antioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomized controlled trial. J Cardiovasc Pharmacol 2001 37 48-54
11. Azevedo E R., Kubo T, Mak S, Al-Hesayen A, Schofield A, Allan R et al. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation 2001 104 2194-2199
12. Poole-Wilson P A., Cleland J G., Di Lenarda A, Hanrath P, Komajda M, Metra M et al. Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET. Eur J Heart Fail 2002 4 321-329
13. Merritt J C., Niebauer M, Tarakji K, Hammer D, Mills R M. Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation. Am J Cardiol 2003 92 735-736
14. Tsuboi J, Kawazoe K, Izumoto H, Okabayashi H. Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting. Circ J 2008 72 588-591
15. Grogan M, Smith H C., Gersh B J., Wood D L. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992 69 1570-1573
16. Aranki S F., Shaw D P., Adams D H., Rizzo R J., Couper G S., VanderVliet M et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996 94 390-397
17. Hashimoto K, Ilstrup D M., Schaff H V. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg 1991 101 56-65
18. Caretta Q, Mercanti C A., De Nardo D, Chiarotti F, Scibilia G, Reale A et al. Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting. Multivariate analysis of preoperative, intraoperative and postoperative variables. Eur Heart J 1991 12 1107-1111
19. Fuller J A., Adams G G., Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J Thorac Cardiovasc Surg 1989 97 821-825
20. Eagle K A., Guyton R A., Davidoff R, Ewy G A., Fonger J, Gardner T J. et al. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation 1999 100 1464-1480 (Pubitemid 29451713)
21. Pires L A., Wagshal A B., Lancey R, Huang S K. Arrhythmias and conduction disturbances after coronary artery bypass graft surgery: epidemiology, management, and prognosis. Am Heart J 1995 129 799-808
22. Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther 2000 68 143-150
23. Metra M, Giubbini R, Nodari S, Boldi E, Modena M G., Dei Cas L. Differential effects of beta-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation 2000 102 546-551
24. Yue T L., Cheng H Y., Lysko P G., McKenna P J., Feuerstein R, Gu J L. et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992 263 92-98
25. Bril A, Slivjak M, DiMartino M J., Feuerstein G Z., Linee P, Poyser R H. et al. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol. Cardiovasc Res 1992 26 518-525